






The limited dividing potential of normal cells leads to 
replicative cellular senescence that is defined by 
irreversible loss of proliferative potential, adoption of 
characteristic morphology and expression of typical 
biomarkers [1, 2]. Cellular senescence acts as a barrier 
to malignant cell transformation in vivo [3] and may 
contribute to organismal ageing [1, 2, 4]. The p53 tumor 
suppressor is a major determinant of cellular senescence 
[5]. It plays a crucial role in the integration of stress 
signaling and coordination of cellular responses to 
stress. Depending on the kind of stress stimuli, stress 
strength and cellular context, activation of tumor 
suppressor p53 can induce reversible quiescence, 
cellular senescence and apoptosis [6]. The function of 
wt p53 is extremely complex and, of course, has to be 
explained within the context of the expression of 
distinct p53 isoforms, levels of p53-induced micro-
RNA and a complex network of p53-interacting 
proteins. Two p53 isoforms (Δ133p53 and p53β), and in 
particular their mutual interaction, seem to act as 
endogenous regulators of cellular senescence in normal 
human fibroblasts [7]. The relevance of these findings 
to  in vivo events reflects the fact that increases in 
Δ133p53 expression and reductions in p53β expression 
have been observed in vivo in colon adenomas with 
senescent phenotypes [8]. 
 
The cancer-protective function of wt p53 is also related 
to its master function in the regulation of various stages 
of apoptosis [9]. However, wt p53 plays a dual role in 
the control of cells’ suicide; depending on stress 
























death. While the apoptosis-promoting function of 
p53tumor suppressor protein has been intensively 
scrutinized and is indisputable, the pro-survival function 
of wt p53 (mediated inter alia via TIGAR, its 
downstream target) has been less explored and due to 
some controversies remains an object of debate. 
However, p53 tumor suppressor has been shown to 
respond to metabolic changes and to influence 
metabolic pathways through several mechanisms. In 
response to a lack of nutrients, p53 becomes activated 
through the activation of AMP-activated protein kinase 
(AMPK) and the inhibition of AKT. p53 protein further 
induces AMPK (both directly and indirectly through the 
sestrins) and activates the expression of tuberous 
sclerosis 2 (TSC2), resulting in the inhibition of mTOR, 
a cytoplamic kinase that transfers signals induced by 
growth factors to cellular machinery promoting cell 
proliferation and survival. 
 
However, cross-talk between p53 and the mTOR 
signaling pathways is more complex. Recent studies 
provide evidence regarding the decision-making role of 
these pathways in the choice between p53-mediated 
cellular quiescence and senescence. The paradoxical 
function of p53, on the one hand repressing cellular 
senescence by promoting quiescence, and on the other 
inducing senescence, has been systematically addressed 
and rigorously studied by M. Blagosklonny and 
colleagues [10-11]. Demidenko et al. [10] have shown 
that suppression of cellular senescence by wt p53 is 
associated with p53-induced quiescence and requires 
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negative regulator of mTOR, favors senescence in 
normal cells [11]. These observations seem to explain 
why limited activation of p53 may prolong the lifespan 
of mice [12] and correlate with observations of age-
related decline in p53 function.  
 
In this issue, Leontieva and Blagosklonny further 
explore the crosstalk between p53 and mTOR in normal 
cells and highlight the role of the functional status of 
mTOR in the transition of cells from quiescence to 
senescence [13]. To separate these activities the authors 
induced quiescence prior to the induction of p53, using 
either the DNA-damaging drug etoposide or nutlin-3a, 
which induces Mdm2-mediated degradation but does 
not damage DNA. After removal of nutlin-3a and serum 
refeeding, nutlin-3a-treated cells entered the cell cycle 
and divided, whereas etoposide-treated cells did not 
proliferate after etoposide removal and serum addition. 
However, etoposide-treated cells re-entered cell cycling 
if co-treated with rapamycin, implying that functional 
mTOR is essential for permanent loss of proliferative 
potential. Thus, this study provides evidence that 
activation of mTOR in quiescent cells is a decision-
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